Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Kazuya TsubouchiNaoki HamadaShoji TokunagaKatsuyuki IchikiShohei TakataHiroshi IshiiYasuhiko KitasatoMasaki OkamotoSatoru KawakamiKazuhiro YateraMasayuki KawasakiMasaki FujitaMakoto YoshidaTakashige MaeyamaTaishi HaradaHiroshi WatayaRyo ToriiMasashi KomoriYuichi MizutaKazunori TobinoEiji HaradaHidetake YabuuchiYoichi NakanishiIsamu OkamotoPublished in: BMJ open respiratory research (2023)
Closer monitoring of disease progression and palliative care interventions after AE are important for non-IPF IIP patients as well as for IPF patients.
Keyphrases
- idiopathic pulmonary fibrosis
- end stage renal disease
- palliative care
- ejection fraction
- newly diagnosed
- chronic kidney disease
- interstitial lung disease
- prognostic factors
- chronic obstructive pulmonary disease
- patient reported outcomes
- intensive care unit
- hepatitis b virus
- extracorporeal membrane oxygenation
- free survival